Tien Liang BioTech Co., Ltd. (TPEX:4127)

Tien Liang BioTech Revenue

Tien Liang BioTech had revenue of 198.27M TWD in the quarter ending March 31, 2026, with 70.04% growth. This brings the company's revenue in the last twelve months to 593.46M, up 54.57% year-over-year. In the year 2025, Tien Liang BioTech had annual revenue of 511.79M with 32.86% growth.

• Revenue (ttm): 593.46M
• Revenue Growth: +54.57%
• P/S Ratio: 5.32
• Revenue / Employee: 6.74M
• Employees: 88
• Market Cap: 3.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	511.79M	126.59M	32.86%
Dec 31, 2024	385.21M	-74.79M	-16.26%
Dec 31, 2023	459.99M	-68.53M	-12.97%
Dec 31, 2022	528.52M	-42.79M	-7.49%
Dec 31, 2021	571.32M	140.23M	32.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error